It’s a kind of control that no one has ever tried before in patients,” Tune’s chief scientific officer said Monday.

The startup raised $40 million in Series A funding its first year ... Tune Therapeutics isn’t the only Triangle biotech startup to have recently raised north of $100 million. In August, the Research ...

Winter weather moves into the Triangle dumping snow for many before it changes it over to sleet, freezing rain Saturday morning ...